Chicago Equity Partners’s West Pharmaceutical WST Stock Holding History

Chicago Equity Partners’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$6.38M	Sell	41,925 -1,710	-4%	-$263K	0.64%	20
2019 Q4	$6.56M	Sell	43,635 -3,910	-8%	-$569K	0.38%	42
2019 Q3	$6.74M	Buy	+47,545	New	+$6.55M	0.32%	66
2017 Q3	–	Sell	-7,770	Closed	-$734K	–	830
2017 Q2	$734K	Buy	+7,770	New	+$715K	0.02%	563
2016 Q3	–	Sell	-16,515	Closed	-$1.25M	–	795
2016 Q2	$1.25M	Buy	16,515 +4,160	+34%	+$303K	0.04%	360
2016 Q1	$856K	Buy	12,355 +820	+7%	+$49.3K	0.03%	384
2015 Q4	$695K	Buy	+11,535	New	+$694K	0.02%	424

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Chicago Equity Partners's WST Position: Q1 2020 in Review

Chicago Equity Partners reduced its West Pharmaceutical (WST) stake by 3.9% in Q1 2020, selling an estimated $263K and leaving 41,925 shares worth $6.38M. The position accounts for 0.64% of the portfolio, ranked #20.

Chicago Equity Partners first reported a position in WST in Q4 2015 and has held it in 7 quarters since. The position peaked at $6.74M in Q3 2019. 468 funds tracked by Wall St. Rank hold WST as of Q1 2020.

Chicago Equity Partners held 41,925 shares of West Pharmaceutical worth $6.38M as of Q1 2020.
Chicago Equity Partners sold 1,710 West Pharmaceutical shares in Q1 2020, an estimated $263K.
West Pharmaceutical made up 0.64% of Chicago Equity Partners's portfolio in Q1 2020, its #20 holding.
Chicago Equity Partners first reported a position in West Pharmaceutical in Q4 2015 and has held it in 7 quarters since.
Chicago Equity Partners's West Pharmaceutical position peaked at $6.74M in Q3 2019.
468 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.